Desmopressin (DDAVP) Responsiveness in Children With von Willebrand Disease
- 1 November 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 25 (11) , 874-879
- https://doi.org/10.1097/00043426-200311000-00010
Abstract
To determine the pattern and predictors of response to desmopressin (DDAVP) in children with von Willebrand disease (VWD). The authors reviewed the hospital records of all children with type 1 (n = 70) and type 2A (n = 5) VWD who were followed in the institution's Bleeding Disorders Clinic from January 1989 to June 2001 and who had a DDAVP challenge test after diagnosis. The major outcome evaluated was response to DDAVP, defined as an increase of greater than twofold over baseline of von Willebrand factor, ristocetin cofactor (VWF:RCo), and factor VIII coagulant (FVIII:C) and levels above 0.3 IU/mL. Response to DDAVP was observed in 56 (80%) of the 70 children with type 1 VWD. Age and baseline VWF:RCo and FVIII:C levels were positively associated with DDAVP response. A total of 36 children (28 responders, 8 nonresponders) with type 1 VWD were treated for bleeding episodes or for prophylaxis; of these 75% (6/8) of the nonresponders compared with 7% (2/28) of the responders to a DDAVP challenge test received blood component therapy (P DDAVP challenge tests are recommended in children with newly diagnosed VWD to identify responders in whom DDAVP may be used for the prevention or treatment of bleeding, thus avoiding exposure to blood products. The association of DDAVP response with age merits further investigation.Keywords
This publication has 26 references indexed in Scilit:
- How I treat patients with von Willebrand diseaseBlood, 2001
- DDAVP IS NOT A PANACEA FOR CHILDREN WITH BLEEDING DISORDERSBritish Journal of Haematology, 2000
- The Effect of DDAVP Infusion on Thrombin Generation in Platelet-rich Plasma of von Willebrand Type 1 and in Mild Haemophilia A PatientsThrombosis and Haemostasis, 2000
- Desmopressin (DDAVP) in Bleeding Disorders of ChildhoodSeminars in Thrombosis and Hemostasis, 1998
- Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disordersEuropean Journal of Anaesthesiology, 1997
- Desmopressin - a haemostatic drugEuropean Journal of Anaesthesiology, 1997
- Preliminary Data from a Field Trial of the PFA-100™ SystemSeminars in Thrombosis and Hemostasis, 1995
- DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendotheliumBlood, 1984
- Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's DiseaseBritish Journal of Haematology, 1981
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975